These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Rules for prevention and certification of occupational diseases in workers occupationally exposed to antineoplastic drugs]. Walusiak J, Wagrowska-Koski E, Pałczyński C. Med Pr; 2001; 52(1):39-44. PubMed ID: 11424747 [Abstract] [Full Text] [Related]
9. OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration. Yodaiken RE, Bennett D. Am J Hosp Pharm; 1986 May; 43(5):1193-204. PubMed ID: 3717176 [Abstract] [Full Text] [Related]
18. Occupational risk in health care and research. Vecchio D, Sasco AJ, Cann CI. Am J Ind Med; 2003 Apr; 43(4):369-97. PubMed ID: 12645094 [Abstract] [Full Text] [Related]
19. [Is there an increase risk of cancer, reproduction complications and toxic events in workers exposed to antineoplastic agents?]. Cañón-Montañez W, Rodríguez-Acelas AL. Enferm Clin; 2010 Apr; 20(3):208-9. PubMed ID: 20452264 [No Abstract] [Full Text] [Related]